Mr. Derek Tierney:

The Chair may be referring to ring-fenced funding on the Sláintecare innovation fund, which is a very small part of the overall funding allocated towards achieving Sláintecare. He is right, in that we dropped that from €8 million to €5 million from 2024 to 2025 but this is just to recognise innovation has now been mainstreamed within the HSE. We do not have to prime that innovation as a separate stand-alone.